 This study suggests that APOL1 variants are associated with increased levels of inflammation in mononuclear cells, which can lead to a decrease in lysosomal integrity. This decreased lysosomal integrity could potentially contribute to the increased risk of cardiovascular disease seen in individuals with APOL1 variants. This article was authored by Ashii D. Blazer, Miao Chang, Kimberley Robbins, and others.